Staurosporine ≥98%

Supplier: MP Biomedicals

Synonyms: (5S,6R,7R,9R)-6-Methoxy-5-methyl-7-(methylamino)-6,7,8,9,15,16-hexahydro-5H,14H-17-oxa-4b,9a,15-triaza-5,9-methanodibenzo[b,h]cyclonona[jkl]cyclopenta[e]-as-indacen-14-one, Antibiotic AM-2282

0219140091 0219140080 0219140090
ICNA0219140091EA 2400 SGD
ICNA0219140091 ICNA0219140080 ICNA0219140090
Staurosporine ≥98%
Staurosporine

Staurosporine is provided in a lyophilised form. It may be reconstituted by dissolving the lyophilised reagent in DMSO (5 mg/ml - clear, colourless solution), DMF, ethyl acetate (5 mg/ml - clear colourless solution) or methanol. Stock solutions should be further diluted with aqueous buffers just prior to use. Stability depends upon the quality of solvent used. The compound should be stored at −20 °C in the dark.


Potent inhibitor of phospholipid/calcium-dependent protein kinase. Inhibits the upregulation of VEGF expression in tumor cells.

Formula: C₂₈H₂₆N₄O₃
MW: 466,541 g/mol
MDL Number: MFCD18252446
CAS Number: 62996-74-1

Order Now

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR